Ticker Details
Insulet Corporation Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
IPO Date:	May 15, 2007
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$10.73B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.80 | 1.89%
Avg Daily Range (30 D):	$3.77 | 2.20%
Avg Daily Range (90 D):	$3.39 | 1.61%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	1.21M
Avg Daily Volume (90 D):	.99M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	38
Avg Trade Size (Sh.) (90 D):	33

Institutional Trades
Total Institutional Trades:	10,211
Avg Institutional Trade:	$6.25M
Avg Institutional Trade (30 D):	$10.47M
Avg Institutional Trade (90 D):	$13.93M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$11.43M
Avg Closing Trade (30 D):	$30.85M
Avg Closing Trade (90 D):	$33.87M
Avg Closing Volume:	60.25K

News

Apr 29, 2026 @ 6:30 PM FDA Flags High-Risk Recall Of Insulet's Omnipod 5 ... Source: Vandana Singh

Apr 21, 2026 @ 8:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Mar 15, 2026 @ 11:05 PM This Biotech Stock Up Nearly 100% in a Year Has Dr... Source: Jonathan Ponciano

Mar 13, 2026 @ 1:45 PM Insulet Stock Hits 52-Week Low - Here's Why Source: Vandana Singh

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$4.3	$1.3	$1.44
Diluted EPS	$4.29	$1.3	$1.43
Revenue	$2.9B	$761.7M	$783.8M
Gross Profit	$2.06B	$529.1M	$568.6M
Net Income / Loss	$302.8M	$91.1M	$101.6M
Operating Income / Loss	$507.2M	$122.1M	$146.3M
Cost of Revenue	$841M	$232.7M	$215.2M
Net Cash Flow	$-802.6M	$-235.7M	$-41.3M
PE Ratio